Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$MOLN Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.37 up 9.76% YoY • Molecular Partners forecasts full-year 2026 total operating expenses of CHF50M at constant exchange rates, including approximately CHF5M of non-cash effective costs; cash is expected to fund operations into late 2027.

Price since post

Full Details

Advertisement|Remove ads.